Page 137 - 南京医科大学学报自然科学版
P. 137
第43卷第6期 黄家晖,顾莹莹,沈 楠,等. PET/CT在食管癌中的应用进展[J].
2023年6月 南京医科大学学报(自然科学版),2023,43(6):876-880 ·879 ·
可用于评估食管癌放疗或放化疗的早期疗效,且治 mum standardized uptake value,and tumor stage[J].
疗中与治疗前 SUVmax的降低值是 2 年 PFS 和局部区 Nucl Med Commun,2013,34(1):40-46
11
域控制的重要预测因子。4′⁃[甲基⁃ C]硫胸苷(4′⁃ [6] NAKAJO M,JINGUJI M,NAKABEPPU Y,et al. Texture
18
analysis of F⁃FDG PET/CT to predict tumour response
11
11
[Methyl⁃ C]thiothymidine,C⁃4DST)是一种与 DNA
and prognosis of patients with esophageal cancer treated
结合的体内细胞增殖标志物,其摄取量与 Ki⁃67
by chemoradiotherapy[J]. Eur J Nucl Med Mol Imaging,
增殖指数高度相关,研究发现食管癌原发灶中
2017,44(2):206-214
11 C⁃4DST较高的积聚与较差的OS及PFS相关 [36] ,且
18
[7] WANG F,GUO R,ZHANG Y,et al. Value of F⁃FDG
C⁃4DST PET/CT 评估食管癌患者预后的价值可能 PET/MRI in the preoperative assessment of resectable
11
优于 F⁃FDG PET/CT。 C⁃蛋氨酸( C⁃methionine, esophageal squamous cell carcinoma:a comparison with
18
11
11
C⁃MET)是目前最常用的氨基酸类显像剂,能够在 18 F⁃FDG PET/CT,MRI,and contrast⁃enhanced CT[J].
11
活体状态下反映氨基酸的转运、代谢和蛋白质的合 Front Oncol,2022,12:844702
成,一项研究发现,食管癌患者碳离子放疗后的肿瘤残 [8] JIANG C,CHEN Y,ZHU Y,et al. Systematic review and
18
meta⁃analysis of the accuracy of F⁃FDG PET/CT for de⁃
留率与治疗后 C⁃MET PET/CT的SUVmax呈正相关 。
[37]
11
tection of regional lymph node metastasis in esophageal
6 小结与展望 squamous cell carcinoma [J]. J Thorac Dis,2018,10
(11):6066-6076
PET 作为一种无创性影像学技术手段,在临床
[9] LI B,LI N,LIU S,et al. Does[18F]fluorodeoxyglucose⁃
得到了广泛应用。新型显像剂的不断涌现预示着
positron emission tomography/computed tomography have
PET在肿瘤诊治方面有广阔前景。目前,F⁃FDG仍 a role in cervical nodal staging for esophageal squamous
18
是临床运用最广泛的显像剂,F⁃FDG PET/CT 在判 cell carcinoma?[J]. J Thorac Cardiovasc Surg,2020,160
18
断食管癌远处转移方面具有优势,但在细化分期、 (2):544-550
评估疗效、选择时机、推测预后等方面尚存在争议, [10] CHU L,LIU S,GUO T,et al. Is Performance of fluorine⁃18⁃
缺乏共识的量化指标,仍需要大量样本进一步研究 fluorodeoxyglucose positron emission tomography/comput⁃
证实。随着定量代谢参数、影像组学纹理分析、机 ed tomography(CT)or contrast ⁃ enhanced CT efficient
enough to guide the hilar lymph node staging for patients
器学习等新方法的应用以及新兴分子探针的研制,
with esophageal squamous cell carcinoma? [J]. Front
PET/CT必将为临床提供更多有效信息及治疗方式。
Oncol,2022,12:814238
[参考文献] [11] 刘晓妮,贺利霞,蒋 洁. EUS联合PET⁃CT检查对食管
癌术前T、N分期诊断的临床价值[J].中国CT和MRI杂
[1] SUNG H,FERLAY J,SIEGEL R L,et al. Global cancer
志,2018,16(12):78-80
statistics 2020:GLOBOCAN estimates of incidence and
[12] XU M,WANG L,OUYANG M,et al. Prediction of lymph
mortality worldwide for 36 cancers in 185 countries[J].
node metastasis by PET/CT metabolic parameters in pa⁃
CA A Cancer J Clin,2021,71(3):209-249
tients with esophageal squamous cell carcinoma[J]. Nucl
[2] HUANGYC,LU H I,HUANG S C,et al. FDG pET using
Med Commun,2019,40(9):933-939
SUVmax for preoperative T ⁃ staging of esophageal squa⁃
[13] YOU J J,WONG R K,DARLING G,et al. Clinical utility
mous cell carcinoma with and withont neadiuvant chemo⁃
18
of F ⁃ fluorodeoxyglucose positron emission tomography/
radiotheroly[J]. BMC Med Imaging,2017,17(1):1
computed tomography in the staging of patients with
[3] CUELLAR S L,CARTER B W,MACAPINLAC H A,et
potentially resectable esophageal cancer [J]. J Thorac
al. Clinical staging of patients with early esophageal ade⁃
Oncol,2013,8(12):1563-1569
nocarcinoma:does FDG⁃PET/CT have a role?[J]. J Tho⁃
[14] ANDEREGG M C,DE GROOF E J,GISBERTZ S S,et al.
rac Oncol,2014,9(8):1202-1206
18
[4] MUIJS C T,BEUKEMA J C,PRUIM J,et al. A systematic F⁃FDG PET⁃CT after neoadjuvant chemoradiotherapy in
review on the role of FDG⁃PET/CT in tumour delineation esophageal cancer patients to optimize surgical decision
and radiotherapy planning in patients with esophageal making[J]. PLoS One,2015,10(11):e0133690
cancer[J]. Radiother Oncol,2010,97(2):165-171 [15] LI C,LIN J W,YEH H L,et al. Good prediction of treat⁃
[5] DONG X,XING L,WU P,et al. Three⁃dimensional posi⁃ ment responses to neoadjuvant chemoradiotherapy for
tron emission tomography image texture analysis of esopha⁃ esophageal cancer based on preoperative inflammatory
status and tumor glucose metabolism[J]. Sci Rep,2021,
geal squamous cell carcinoma :relationship between
18
tumor F⁃fluorodeoxyglucose uptake heterogeneity,maxi⁃ 11(1):11626